← back to search

Alexander Aliper

Abu Dhabi University ·
Area of research
Molecular Biology · Computational Theory and Mathematics
Research interest
Research interests include Computational Drug Discovery Methods, Bioinformatics and Genomic Networks, Gene Regulatory Network Analysis, and Genetics, Aging, and Longevity in Model Organisms.
h-index
35
citations
5,186
works
79
NIH funding
primary concept
email

Recent publications

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform
Frontiers in Aging Neuroscience 2022cited by 96position: middledoi
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine
Aging 2022cited by 81position: middledoi
Blood Biochemistry Analysis to Detect Smoking Status and Quantify Accelerated Aging in Smokers
Scientific Reports 2019cited by 116position: middledoi
Population Specific Biomarkers of Human Aging: A Big Data Study Using South Korean, Canadian, and Eastern European Patient Populations
The Journals of Gerontology Series A 2018cited by 193position: middledoi
Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization
Oncotarget 2018cited by 81position: middledoi
Aging and drug discovery
Aging 2018cited by 35position: middledoi
Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare
Oncotarget 2017cited by 470position: middledoi
Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic data
Cell Cycle 2017cited by 70position: middledoi
Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data
Molecular Pharmaceutics 2016cited by 598position: firstdoi
Deep biomarkers of human aging: Application of deep neural networks to biomarker development
Aging 2016cited by 376position: middledoi
The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology
Oncotarget 2016cited by 364position: middledoi
Design of efficient computational workflows for in silico drug repurposing
Drug Discovery Today 2016cited by 158position: middledoi
In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development
Nature Communications 2016cited by 140position: middledoi
DNA repair in species with extreme lifespan differences
Aging 2015cited by 192position: middledoi
Molecular aspects of development and regulation of endometriosis
Reproductive Biology and Endocrinology 2014cited by 112position: middledoi
Pathway activation profiling reveals new insights into Age-related Macular Degeneration and provides avenues for therapeutic interventions
Aging 2014cited by 51position: middledoi
Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene<i>PRODH</i>
Proceedings of the National Academy of Sciences 2013cited by 82position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alex Zhavoronkov · Zhejiang Medicine (China)16 papers (2013–2022)Polina Mamoshina · Longevity Biotech (United States)8 papers (2016–2019)Charles R. Cantor · Advisory Board Company (United States)6 papers (2013–2019) · 5 papers (2016–2022)Anton Buzdin · Centre of Advanced Studies4 papers (2013–2017) · 4 papers (2017–2019) · 3 papers (2016–2017)Evgeny Izumchenko · University of Chicago3 papers (2016–2022)Jan Vijg · Montefiore Medical Center3 papers (2015–2016)Alexey Moskalev · National Research Center for Preventive Medicine3 papers (2016–2022)Artem V. Artemov · Austrian Research Institute for Artificial Intelligence3 papers (2016–2016) · 3 papers (2016–2016)Morten Scheibye‐Knudsen · University of Copenhagen3 papers (2018–2019)Ju Wang · Xuzhou University of Technology2 papers (2022–2022)Feng Ren · The First Affiliated Hospital, Sun Yat-sen University2 papers (2022–2022) · 2 papers (2018–2019)Franco Cortese · Queen's University2 papers (2018–2019)Vadim N. Gladyshev · Harvard University2 papers (2015–2018) · 2 papers (2018–2019) · 2 papers (2022–2022)